MT200605   Click here for help

GtoPdb Ligand ID: 14752

Synonyms: compound 1 [WO2020024977] | MT-200605
Compound class: Synthetic organic
Comment: MT200605 is a small-molecule tropomyosin receptor kinase B (TrkB; NTRK2) agonist [2], that mimics the effect of endogenous agonist (brain-derived neurotrophic factor, BDNF)-mediated receptor activation and downstream signalling [1]. This mechanism is proposed for neuroprotective action, to inhibit ischaemic-reperfusion injury following cerebral stroke.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 2
Topological polar surface area 70
Molecular weight 337.37
XLogP 2.9
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1CCN(CC1)C2=CC=C(C=C2)C3=CC(=O)C4=CC=C(C(=C4O3)O)O
Isomeric SMILES OC1=CC=C2C(C=C(OC2=C1O)C3=CC=C(C=C3)N4CCCCC4)=O
InChI InChI=1S/C20H19NO4/c22-16-9-8-15-17(23)12-18(25-20(15)19(16)24)13-4-6-14(7-5-13)21-10-2-1-3-11-21/h4-9,12,22,24H,1-3,10-11H2
InChI Key SDXFTJNNRCYVGZ-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
MT200605 was progressed as a clinical candidate, with first-in-human phase 1 results published in September 2026 [1].
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05948774 A SAD/MAD Study to Evaluate the Safety, Tolerability, PK of MT200605 in Healthy Subjects Phase 1 Interventional Shaanxi Micot Pharmaceutical Technology Co., Ltd.
NCT07205328 A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke Phase 2 Interventional Shaanxi Micot Pharmaceutical Technology Co., Ltd.